MedTrace Logo

Glucose Risk Assessment in Employer Populations

NCT04529824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2023-02-15

No results posted yet for this study

Summary

This is an observational study to understand the glucose characteristics of the general population (normal glucose, pre-diabetes, and diabetes). Glucose risk will be measured with laboratory HbA1c and continuous glucose monitor (CGM) derived metrics. Physical activity will also be measured using a Fitbit activity tracker. The study will inform future programs that use CGM and activity tracking to identify people at risk for diabetes in the population.

Conditions

  • Diabetes
  • Pre-diabetes
  • Glucose Intolerance

Interventions

DEVICE

Dexcom G6 Continuous Glucose Monitor (CGM) System

Participants wear a blinded Dexcom G6 CGM and a Fitbit Charge 3 activity tracker for 10 days.

Sponsors & Collaborators

  • DexCom, Inc.

    lead INDUSTRY

Principal Investigators

  • David Price, MD · DexCom, Inc.

  • Jennifer Ksailbati, CCRP · MOORE Clinical Research, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-07-22
Completion
2021-08-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529824 on ClinicalTrials.gov